Skip to main content
. 2018 Oct 26;21(Suppl Suppl 8):e25187. doi: 10.1002/jia2.25187

Abstract P203 – Table 2. DTG discontinuation due to NAEs

n %
Discontinuations due to neuropsychiatric AEs 32 5
Naive 5 7
 ABC backbone/n tot ABC 2 0.9
 TDF/TAF backbone/n tot tenofovir 3 2.6
Experienced 27 4.8
 Dual 13
 Triple 14
 ABC backbone/n tot ABC 7 3
 TDF/TAF backbone/n tot tenofovir 7 6.1
Previous neuropsychiatric disorders or psychiatric drugs 8 25
Resolution after ART modification 30 93.7